The Boston Scientific ENDOTAK RELIANCE DF1 Defibrillation Lead (REF 183) is a transvenous endocardial defibrillation lead designed for connection to compatible implantable cardioverter defibrillator (ICD) pulse generators using the DF1/IS-1 connector standard. The ENDOTAK RELIANCE family is engineered to provide reliable sensing, pacing, and high-voltage defibrillation therapy delivery in the right ventricle.
Key Features
- DF1/IS-1 connector configuration for compatibility with DF1-compatible ICD pulse generators
- Transvenous endocardial placement in the right ventricle
- Designed to deliver bradycardia pacing, sensing, and high-voltage defibrillation therapy
- Integrated shocking coil(s) for defibrillation energy delivery
- Silicone and/or polyurethane lead body construction consistent with the ENDOTAK RELIANCE platform
- Fixation mechanism consistent with the ENDOTAK RELIANCE model family
- Manufactured by Boston Scientific to established ICD lead engineering standards
Clinical Applications
- Use with compatible implantable cardioverter defibrillator (ICD) systems
- Right ventricular sensing and pacing in patients indicated for ICD therapy
- Delivery of high-voltage defibrillation therapy for the treatment of life-threatening ventricular tachyarrhythmias
- Intended for chronic transvenous endocardial implantation by qualified electrophysiology and cardiac implant specialists
Product Information
- Brand: Boston Scientific
- Product Line: ENDOTAK RELIANCE
- Model / REF: 183
- Category: ICD Leads for Implantable Cardioverter Defibrillators
- Connector: DF1 / IS-1 configuration
- Lead Type: Transvenous endocardial defibrillation lead
- Lead Length: Not specified in the located sources
- Fixation Type: Not specified in the located sources
- Number of Shocking Coils: Not specified in the located sources
- Sterility: Supplied sterile for single use, per manufacturer labeling
- Packaging / Storage: Refer to manufacturer Instructions for Use (IFU)
- Regulatory: Refer to Boston Scientific labeling and IFU for approved indications and market-specific clearances